Immunocyte-derived amyloid light chain (AL) (primary) amyloidosis is the most common form of systemic amyloidosis and, of all the amyloidoses, is associated with the shortest survival rate (1) . In the majority of cases, this disease is associated with a nonmalignant expansion of a single plasma cell clone. It is the monoclonal immunoglobulin light chain product of the plasma cell clone which is the precursor of the amyloid fibril subunit protein (2) .
A number of clinically observed features of AL amyloidosis suggest that structure of the immunoglobulin light chain subunit protein is an important factor in the pathogenesis of this disease. First, while the ratio of K to A plasma cell clones and proteins in the human is 3:2, more individuals with A light chain-derived amyloid are identified than with K proteins. Second, within the A light chain subgroups, the A VI proteins *have been found to be particularly amyloidogenic (3, 4) . Third, K I light chain proteins represent the majority of K amyloid proteins and primary structure analyses have suggested substitutions in key framework regions as being associated with amyloid fibril formation (5) (see Fig. 1 ).
To investigate structural factors which may be important for amyloid fibril formation from immunoglobulin light chain proteins, an attempt has been made to compare the structure of the variable region of an amyloid light chain protein with the structure of nonamyloid light chain proteins. The goal is to develop a structural model for the polymerization or aggregation process of immunoglobulin light chain proteins which leads to amyloid fibril formation. A K I protein from an individual with amyloidosis was completely characterized at the primary structure level.
By using the determined amino acid sequence, oligonucleotide primers were constructed and used to amplify from the patient's bone marrow DNA the sequence coding for the entire variable segment of the K I light chain. § The DNA construct was then used to express the recombinant variable region of the light chain (VL) of the K I protein in vitro. This protein was crystallized, and its tertiary structure was determined by x-ray diffraction.l
MATERIALS AND METHODS
Isolation and Characterization ofLight Chain Protein BRE. Light chain protein was isolated from the urine of patient BRE (hereafter referred to as BRE protein or BRE) by precipitation in 60% ammonium sulfate followed by chromatography on DEAE cellulose and ACA-34 (Pharmacia). Amino acid sequence analysis was performed on a Beckman 890C sequenator as described (4) . For a complete structure, the BRE protein was digested with L-1-tosylamido-2-phenylethyl chloromethyl ketone (TPCK)-treated trypsin and resultant peptides separated on a C18 HPLC column.
DNA Isolation and Plasmid Construction for Expression of Recombinant Protein. DNA was isolated from bone marrow cells of patient BRE by using the method of Madisen et al. (6) . On the basis of the amino acid sequence of BRE protein and published sequences of the signal peptide for K I proteins (7), oligonucleotide primers were constructed (see Fig. 2 ). The resultant PCR amplification product was then ligated into pCZ11, a thermoinducible replication vector, and used to transform competent Escherichia coli strain HB101 (8 Large Scale Growth and Protein Isolation. Cells containing the desired plasmid were grown in 200 ml of TY broth (0.8% tryptone/1% yeast extract/0.25% NaCl) overnight at 23°C as described (8 Table 1 ). Molecular replacement (rotation and translation searches together with Patterson correlation refinement) was performed with X-PLOR (11, 12) by using data in the 15-to 3.5-A shell and the refined REI structure as the search model (13) . Each independent solution from the cross-rotation function after PC refinement (11) was used in a translation search in the a and c directions since this space group requires only a search in x and z. The best solution for the first translation function gave the position of dimer 1 in the asymmetric unit. To determine the relative position of dimer 2 and 3 with respect to dimer 1, we used combined translation functions (11) (12) , the crystallographic R factor dropped to 21 .8% for all data in the resolution range 5.0-2.0 A. To assess the quality of the refinement, we used the free R-factor test in X-PLOR (17) . The high value (Rfree 33.7%) indicated possible overfitting of our model. To improve the data-to-parameter ratio, we included noncrystallographic symmetry restraints and repeated the refinement with X-PLOR (12, 14) . The crystallographic R factor converged at 22.9% (Rfree 26%). Finally, we subjected the model to 10 cycles of restrained least-squares refinement by using PROLSQ (18) . The current model consists of 4974 protein atoms (107 of the 108 residues modeled) and 40 water molecules (see Table 2 ). 
RESULTS AND DISCUSSION
Sequence analysis of intact protein BRE isolated from the urine of a patient with systemic amyloidosis identified it as belonging to the K I subgroup. The complete sequence of its VL region was determined by analysis of peptides obtained after digestion with trypsin. Comparison of BRE VL sequence to other K I amyloid associated proteins showed a few unique residues, including Ile-34, Leu-40, and (Fig. 1) .
By using oligonucleotide primers based on the amino acid sequence of BRE VL and published K I signal peptides, PCR amplification of bone marrow DNA from patient BRE gave a product of expected size which by direct sequencing was shown to have nucleotide sequence in agreement with the protein structure of BRE VL (Fig. 2) . Ligation of this DNA construct into pCZ11 and expression in E. coli produced a protein of approximately 12,000 Da. This protein reacted specifically with an antiserum raised against the BRE urine light chain. Recombinant BRE protein was purified to homogeneity and crystallized by using ammonium sulfate as precipitant. Diffraction data to 1.75-A resolution were collected in two crystal forms ( Table 1 ). The structure of the BRE VL K domain in crystal form I was determined by x-ray diffraction and refined to 2 A (Table 2 ). The BRE VL K domain crystallizes as a dimer, as found for proteins ROY and REI (9, 13) . The tertiary structure of BRE is similar to other A and K light chain fragments in that the monomer is composed of a (3-barrel formed from nine antiparallel ,3-strands arranged in two sheets packed against each other, with two monomers making a Bence Jones-type dimer (Fig. 3) . Two forms of interdomain contacts can be seen along the two types of local diads. Amino acid residues Tyr-36, Glu-38, Pro-44, Asn-45, Tyr-87, and Phe-98 of both monomers participate in the monomer-monomer contact region, as described for REI (13) . The contact region between the noncovalent dimers is formed by amino acid residues Ser-9, Ser-10, and Ser-12 extending the hydrogen bonding network and by Pro-8 and Leu-11 making hydrophobic contacts.
Sequence comparison of BRE with REI shows the altered residues and their assignment to FRs and complementaritydetermining regions (CDRs) (Fig. 4) . Comparison with the published tertiary structure of REI (13) was accomplished by superimposition of the structures by using a least-squares procedure. Significant differences in the position of residues in the hypervariable segments (residues 28-32, 50-53, and 91-96), as well as variations in FR segments 40-46 (FR2) and 66-67 (FR3), are seen. The largest difference between BRE and REI monomers is in the 40-44 loop which forms part of the dimer interface, partly due to a substitution of Leu for Pro at residue 40. This substitution also introduces a hydrophobic residue into a hydrophilic environment since residue 40 is exposed to the solvent. Important positional differences of residues involved in monomer-monomer interactions at the dimer interface and in monomer-monomer interactions along the dimer-dimer contact region are seen ( Fig. 5 A and B (Fig. 6 ). This would allow a structure that can be visualized as a spiral with six light chain dimers and a rise of approximately the diameter of two dimers per turn of 360° (Fig. 7) . This model fits well with the dimensions noted by electron microscopy for fibrils of approximately 10 nm (100 A) in diameter and indeterminate length.
As for TTR, structural alterations are found in immunoglobulin protein(s) associated with amyloidosis when compared with their nonamyloid counterparts. These changes usually involve residues at the interface (monomer-monomer and dimer-dimer interactions). Both light chain proteins and TTR variants show an extensive /3-sheet framework believed to be a prerequisite for fibril formation. In TTR variants, singlesite substitutions lead to structural perturbations, but so far all variants studied crystallographically crystallize isomorphously (same space group, very similar unit-cell parameters)-i.e., their packing mode is preserved (25) . To via the cysteine residue (TTR residue 10) have been suggested as factors in this process (26, 27) . The fibril model presented here for an amyloid-associated K light chain shows a change in packing mode when compared with nonamyloid light chain proteins such as REI and ROY and is consistent with dimensions of amyloid fibrils determined by electron microscopy. While REI shows a regular hexagonal spiral structure (28) , because of its unique primary structure it may be predisposed to form crystals in vivo rather than fibrils. This may be a basis for "myeloma kidney" seen in individuals with large amounts of Bence Jones proteins which do not form amyloid fibrils. We believe that the pseudohexagonal packing arrangement is not an artifact of crystal forces but a direct result of positional changes seen in our model, especially in the contact regions, and that this perturbation makes BRE more susceptible to amyloid fibril formation in vivo. The dimer-dimer contact region is probably more important in the aggregation process of light chain dimers than the dimer interface.
The model presented here can be tested by studying the tertiary structure of other amyloidogenic immunoglobulin light chain proteins of both subtypes (K and A). If this model holds, it may then be possible to identify key residues responsible for the transformation.
